Aptevo Therapeutics Inc. - Common Stock, $0.001 par value (APVO)
CUSIP: 03835L306
Q1 2024 13F Holders as of 31 Mar 2024
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 2,864,322
- Total 13F shares
- 2,643
- Share change
- +2,643
- Total reported value
- $12,395
- Price per share
- $4.69
- Number of holders
- 10
- Value change
- +$12,395
- Number of buys
- 10
Quarterly Holders Quick Answers
What is CUSIP 03835L306?
CUSIP 03835L306 identifies APVO - Aptevo Therapeutics Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q2 2024
Recent filing periods for CUSIP 03835L306:
Top shareholders of APVO - Aptevo Therapeutics Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
—
class O/S missing
|
516,789
|
$94,000 | — | 31 Dec 2023 | |
| SABBY MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
349,471
|
$63,254 | — | 31 Dec 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
—
class O/S missing
|
262,124
|
$47,444 | — | 31 Dec 2023 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
—
class O/S missing
|
159,000
|
$28,778 | — | 31 Dec 2023 | |
| Squarepoint Ops LLC |
13F
|
Company |
—
class O/S missing
|
138,697
|
$25,104 | — | 31 Dec 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
104,608
|
$18,934 | — | 31 Dec 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
—
class O/S missing
|
91,725
|
$16,602 | — | 31 Dec 2023 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
—
class O/S missing
|
61,130
|
$11,065 | — | 31 Dec 2023 | |
| CANTOR FITZGERALD, L. P. |
13F
|
Individual |
—
class O/S missing
|
58,532
|
$10,594 | — | 31 Dec 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
—
class O/S missing
|
46,635
|
$8,441 | — | 31 Dec 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
43,201
|
$7,819 | — | 31 Dec 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
—
class O/S missing
|
14,121
|
$2,556 | — | 31 Dec 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
—
class O/S missing
|
13,660
|
$2,472 | — | 31 Dec 2023 | |
| MORGAN STANLEY |
13F
|
Company |
—
class O/S missing
|
11,370
|
$2,058 | — | 31 Dec 2023 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
—
class O/S missing
|
11,248
|
$2,036 | — | 31 Dec 2023 | |
| Baader Bank Aktiengesellschaft |
13F
|
Company |
—
class O/S missing
|
15,086
|
$2,026 | — | 31 Dec 2023 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
—
class O/S missing
|
10,997
|
$1,990 | — | 31 Dec 2023 | |
| STATE STREET CORP |
13F
|
Company |
—
class O/S missing
|
10,941
|
$1,980 | — | 31 Dec 2023 | |
| Divergent Wealth Advisors |
13F
|
Company |
—
class O/S missing
|
10,000
|
$1,810 | — | 31 Dec 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
—
class O/S missing
|
1,897
|
$343 | — | 31 Dec 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
—
class O/S missing
|
1,617
|
$293 | — | 31 Dec 2023 | |
| FIFTH THIRD BANCORP |
13F
|
Company |
—
class O/S missing
|
291
|
$53 | — | 31 Dec 2023 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
—
class O/S missing
|
142
|
$26 | — | 31 Dec 2023 | |
| Truvestments Capital LLC |
13F
|
Company |
—
class O/S missing
|
95
|
$17 | — | 31 Dec 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
—
class O/S missing
|
30
|
$5 | — | 31 Dec 2023 | |
| Allworth Financial LP |
13F
|
Company |
—
class O/S missing
|
17
|
$4 | — | 31 Dec 2023 | |
| CITIGROUP INC |
13F
|
Company |
—
class O/S missing
|
10
|
$2 | — | 31 Dec 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
class O/S missing
|
6
|
$1 | — | 31 Dec 2023 | |
| UBS Group AG |
13F
|
Company |
—
class O/S missing
|
5
|
$1 | — | 31 Dec 2023 | |
| Fuad El-Hibri |
3/4/5
|
Director |
—
class O/S missing
|
87,697
|
— | — | 03 Dec 2021 |
Institutional Holders of Aptevo Therapeutics Inc. - Common Stock, $0.001 par value (APVO) as of Q1 2024
As of 31 Mar 2024,
Aptevo Therapeutics Inc. - Common Stock, $0.001 par value (APVO) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,643 shares.
The largest 10 holders included
Tower Research Capital LLC (TRC), BlackRock Inc., MORGAN STANLEY, Qube Research & Technologies Ltd, OSAIC HOLDINGS, INC., JPMORGAN CHASE & CO, WELLS FARGO & COMPANY/MN, FIFTH THIRD BANCORP, PNC Financial Services Group, Inc., and Truvestments Capital LLC.
This page lists
10
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2024 vs Q4 2024 Across Filers
Q4 2024 holders
0
Q1 2024 holders
10
Holder diff
10
| Investor | Q4 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.